Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GEN2 |
Trade Name | |
Synonyms | GEN 2|GEN-2 |
Drug Descriptions |
GEN2 comprises a non-replicating retroviral vector expressing herpes simplex virus thymidine kinase (HSV-TK) and GM-CSF, which potentially enhances antitumor immune response and induces tumor cell death (Cancer Res (2024) 84 (6_Supplement): 7250, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C176770 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GEN2 | GEN2 | 0 | 0 |
GEN2 + Valganciclovir | GEN2 Valganciclovir | 0 | 1 |